ISRCTN47481946已完成不适用
Beta Agonist Lung Injury TrIal (BALTI) Prevention Study: a multicentre, double-blind, randomised, placebo-controlled trial
Birmingham Heartlands Hospital (UK)0 个研究点目标入组 360 人开始时间: 2008年2月29日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 360
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Planned elective transthoracic oesophagectomy patients
- •2. Aged greater than 18 years
- •3. Male and female
- •4. Able to provide informed consent
- •5. Able to use a spacer device to deliver the drug
排除标准
- •1. Pregnancy
- •2. Current treatment with long acting beta agonist
- •3. Allergy to excipients in salmeterol
- •4. Current treatment with non-cardioselective beta-blockers
- •5. Treatment with investigational medicinal product (IMP) in the last 30 days
研究者
相似试验
进行中（未招募）
1 期
Beta Agonist Lung injury Trial - Prevention Study - BALTI PreventioEUCTR2007-004096-19-GBBirmingham Heartlands Hospital360
进行中（未招募）
1 期
BALTI-2: Beta Agonists in Lung Injury Trial - BALTI-2EUCTR2006-002647-86-GBHeart of England NHS Foundation Trust1,334
Unknown
不适用
Association of Beta-Blocker Therapy at Discharge With Clinical Outcomes in Patients With Actue Coronary SyndromeActue Coronary SyndromeNCT03658577Shenzhen People's Hospital582
已完成
不适用
The effect of prophylactic bronchodilator treatment with transdermal tulobuterol patch on lung compliance and airway resistanceDiseases of th respiratory systemKCT0001152Pusan National University Hospital82
已完成
4 期
Salbutamol Tolerance OnsetAsthmaNCT01338311University of Saskatchewan15